New Key Statistics Module, Z-Score and F-Score
NAS:BIIB Key Ratios
Market Cap $ M | 30,415.19 |
Enterprise Value $ M | 35,349.75 |
P/E(ttm) | 26.08 |
PE Ratio without NRI | 14.58 |
Forward PE Ratio | 13.62 |
Price/Book | 1.99 |
Price/Sales | 3.11 |
Price/Free Cash Flow | 23.65 |
Price/Owner Earnings | 71.82 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 9,663.00 |
EPS (TTM) $ | 8.01 |
Beneish M-Score | -2.34 |
10-y EBITDA Growth Rate % | 2.20 |
5-y EBITDA Growth Rate % | -15.60 |
y-y EBITDA Growth Rate % | -52.90 |
EV-to-EBIT | 22.42 |
EV-to-EBITDA | 16.78 |
PEG | -- |
Shares Outstanding M | 145.60 |
Net Margin (%) | 12.07 |
Operating Margin % | 19.50 |
Pre-tax Margin (%) | 13.69 |
Quick Ratio | 1.32 |
Current Ratio | 2.10 |
ROA % (ttm) | 4.44 |
ROE % (ttm) | 8.02 |
ROIC % (ttm) | 8.18 |
Dividend Yield % | -- |
Altman Z-Score | 3.23 |
BIIB Number of Guru Trades
BIIB Volume of Guru Trades
Gurus Latest Trades with NAS:BIIB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BIIB is held by these investors
Total 5
Biogen Inc Insider Transactions
No Available Data
News about NAS:BIIB
Total 0- 1